351 related articles for article (PubMed ID: 26695519)
1. The marine triterpene glycoside frondoside A exhibits activity in vitro and in vivo in prostate cancer.
Dyshlovoy SA; Menchinskaya ES; Venz S; Rast S; Amann K; Hauschild J; Otte K; Kalinin VI; Silchenko AS; Avilov SA; Alsdorf W; Madanchi R; Bokemeyer C; Schumacher U; Walther R; Aminin DL; Fedorov SN; Shubina LK; Stonik VA; Balabanov S; Honecker F; von Amsberg G
Int J Cancer; 2016 May; 138(10):2450-65. PubMed ID: 26695519
[TBL] [Abstract][Full Text] [Related]
2. The marine triterpene glycoside frondoside A induces p53-independent apoptosis and inhibits autophagy in urothelial carcinoma cells.
Dyshlovoy SA; Madanchi R; Hauschild J; Otte K; Alsdorf WH; Schumacher U; Kalinin VI; Silchenko AS; Avilov SA; Honecker F; Stonik VA; Bokemeyer C; von Amsberg G
BMC Cancer; 2017 Feb; 17(1):93. PubMed ID: 28143426
[TBL] [Abstract][Full Text] [Related]
3. Corosolic acid, a natural triterpenoid, induces ER stress-dependent apoptosis in human castration resistant prostate cancer cells via activation of IRE-1/JNK, PERK/CHOP and TRIB3.
Ma B; Zhang H; Wang Y; Zhao A; Zhu Z; Bao X; Sun Y; Li L; Zhang Q
J Exp Clin Cancer Res; 2018 Sep; 37(1):210. PubMed ID: 30176898
[TBL] [Abstract][Full Text] [Related]
4. Combined N-terminal androgen receptor and autophagy inhibition increases the antitumor effect in enzalutamide sensitive and enzalutamide resistant prostate cancer cells.
Kranzbühler B; Salemi S; Mortezavi A; Sulser T; Eberli D
Prostate; 2019 Feb; 79(2):206-214. PubMed ID: 30345525
[TBL] [Abstract][Full Text] [Related]
5. Combination of carmustine and selenite effectively inhibits tumor growth by targeting androgen receptor, androgen receptor-variants, and Akt in preclinical models: New hope for patients with castration resistant prostate cancer.
Thamilselvan V; Menon M; Thamilselvan S
Int J Cancer; 2016 Oct; 139(7):1632-47. PubMed ID: 27198552
[TBL] [Abstract][Full Text] [Related]
6. Anticancer Activity of the Marine Triterpene Glycoside Cucumarioside A
Menchinskaya ES; Dyshlovoy SA; Venz S; Jacobsen C; Hauschild J; Rohlfing T; Silchenko AS; Avilov SA; Balabanov S; Bokemeyer C; Aminin DL; von Amsberg G; Honecker F
Mar Drugs; 2023 Dec; 22(1):. PubMed ID: 38248645
[TBL] [Abstract][Full Text] [Related]
7. PDLIM2 suppression efficiently reduces tumor growth and invasiveness of human castration-resistant prostate cancer-like cells.
Kang M; Lee KH; Lee HS; Park YH; Jeong CW; Ku JH; Kim HH; Kwak C
Prostate; 2016 Feb; 76(3):273-85. PubMed ID: 26499308
[TBL] [Abstract][Full Text] [Related]
8. Ericifolin: a novel antitumor compound from allspice that silences androgen receptor in prostate cancer.
Shamaladevi N; Lyn DA; Shaaban KA; Zhang L; Villate S; Rohr J; Lokeshwar BL
Carcinogenesis; 2013 Aug; 34(8):1822-32. PubMed ID: 23568956
[TBL] [Abstract][Full Text] [Related]
9. Frondoside A induces AIF-associated caspase-independent apoptosis in Burkitt lymphoma cells.
Dyshlovoy SA; Rast S; Hauschild J; Otte K; Alsdorf WH; Madanchi R; Kalinin VI; Silchenko AS; Avilov SA; Dierlamm J; Honecker F; Stonik VA; Bokemeyer C; von Amsberg G
Leuk Lymphoma; 2017 Dec; 58(12):2905-2915. PubMed ID: 28508718
[TBL] [Abstract][Full Text] [Related]
10. Small molecule tolfenamic acid inhibits PC-3 cell proliferation and invasion in vitro, and tumor growth in orthotopic mouse model for prostate cancer.
Sankpal UT; Abdelrahim M; Connelly SF; Lee CM; Madero-Visbal R; Colon J; Smith J; Safe S; Maliakal P; Basha R
Prostate; 2012 Nov; 72(15):1648-58. PubMed ID: 22473873
[TBL] [Abstract][Full Text] [Related]
11. β-elemonic acid inhibits growth and triggers apoptosis in human castration-resistant prostate cancer cells through the suppression of JAK2/STAT3/MCL-1 and NF-ĸB signal pathways.
Bao X; Zhu J; Ren C; Zhao A; Zhang M; Zhu Z; Lu X; Zhang Y; Li X; Sima X; Li J; Zhang Q; Ma B
Chem Biol Interact; 2021 Jun; 342():109477. PubMed ID: 33878321
[TBL] [Abstract][Full Text] [Related]
12. Repurposing of phentolamine as a potential anticancer agent against human castration-resistant prostate cancer: A central role on microtubule stabilization and mitochondrial apoptosis pathway.
Ho CH; Hsu JL; Liu SP; Hsu LC; Chang WL; Chao CC; Guh JH
Prostate; 2015 Sep; 75(13):1454-66. PubMed ID: 26180030
[TBL] [Abstract][Full Text] [Related]
13. Marine compound rhizochalinin shows high in vitro and in vivo efficacy in castration resistant prostate cancer.
Dyshlovoy SA; Otte K; Alsdorf WH; Hauschild J; Lange T; Venz S; Bauer CK; Bähring R; Amann K; Mandanchi R; Schumacher U; Schröder-Schwarz J; Makarieva TN; Guzii AG; Tabakmakher KM; Fedorov SN; Shubina LK; Kasheverov IE; Ehmke H; Steuber T; Stonik VA; Bokemeyer C; Honecker F; von Amsberg G
Oncotarget; 2016 Oct; 7(43):69703-69717. PubMed ID: 27626485
[TBL] [Abstract][Full Text] [Related]
14. Frondoside A inhibits human breast cancer cell survival, migration, invasion and the growth of breast tumor xenografts.
Al Marzouqi N; Iratni R; Nemmar A; Arafat K; Ahmed Al Sultan M; Yasin J; Collin P; Mester J; Adrian TE; Attoub S
Eur J Pharmacol; 2011 Oct; 668(1-2):25-34. PubMed ID: 21741966
[TBL] [Abstract][Full Text] [Related]
15. Galeterone and VNPT55 induce proteasomal degradation of AR/AR-V7, induce significant apoptosis via cytochrome c release and suppress growth of castration resistant prostate cancer xenografts in vivo.
Kwegyir-Afful AK; Ramalingam S; Purushottamachar P; Ramamurthy VP; Njar VC
Oncotarget; 2015 Sep; 6(29):27440-60. PubMed ID: 26196320
[TBL] [Abstract][Full Text] [Related]
16. NPRL2 enhances autophagy and the resistance to Everolimus in castration-resistant prostate cancer.
Chen Z; Jiang Q; Zhu P; Chen Y; Xie X; Du Z; Jiang L; Tang W
Prostate; 2019 Jan; 79(1):44-53. PubMed ID: 30178500
[TBL] [Abstract][Full Text] [Related]
17. Pao Pereira Extract Suppresses Castration-Resistant Prostate Cancer Cell Growth, Survival, and Invasion Through Inhibition of NFκB Signaling.
Chang C; Zhao W; Xie B; Deng Y; Han T; Cui Y; Dai Y; Zhang Z; Gao J; Guo H; Yan J
Integr Cancer Ther; 2014 May; 13(3):249-58. PubMed ID: 24287876
[TBL] [Abstract][Full Text] [Related]
18. Butein and Frondoside-A Combination Exhibits Additive Anti-Cancer Effects on Tumor Cell Viability, Colony Growth, and Invasion and Synergism on Endothelial Cell Migration.
Sulaiman S; Arafat K; Al-Azawi AM; AlMarzooqi NA; Lootah SNAH; Attoub S
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008855
[TBL] [Abstract][Full Text] [Related]
19. Exploitation of the Androgen Receptor to Overcome Taxane Resistance in Advanced Prostate Cancer.
Martin SK; Kyprianou N
Adv Cancer Res; 2015; 127():123-58. PubMed ID: 26093899
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of LSD1 by Pargyline inhibited process of EMT and delayed progression of prostate cancer in vivo.
Wang M; Liu X; Guo J; Weng X; Jiang G; Wang Z; He L
Biochem Biophys Res Commun; 2015 Nov; 467(2):310-5. PubMed ID: 26435505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
